Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1100120190260010031
´ëÇÑ°ñ´ë»çÇÐȸÁö
2019 Volume.26 No. 1 p.31 ~ p.38
Effects of Thyrotropin Suppression on Bone Health in Menopausal Women with Total Thyroidectomy
Kim Eun-Heui

Jeon Yun-Kyung
Pak Kyoung-June
Kim In-Joo
Kim Seong-Jang
Shin Seung-Hyeon
Kim Bo-Hyun
Kim Sang-Soo
Lee Byung-Joo
Lee Jeong-Gyu
Goh Tae-Sik
Kim Keun-Young
Abstract
Background: This study examined the change in the trabecular bone score (TBS), areal bone mineral density (aBMD), and osteoporosis in postmenopausal women who underwent thyrotropin (TSH)-suppressive therapy for treating papillary thyroid cancer after a total thyroidectomy procedure.

Methods: We evaluated 36 postmenopausal women who received a total thyroidectomy for papillary thyroid cancer and were undergoing TSH suppressive therapy with levothyroxine. Postmenopausal women (n=94) matched for age and body mass index were recruited as healthy controls. The aBMD and TBS of the lumbar spine were compared between dual energy X-ray absorptiometry (DXA) at baseline and at follow-up after an average of 4.92 years.

Results: There was no significant difference in the rate of diagnoses of osteoporosis, osteopenia, or normal bone status between the 2 groups during the baseline DXA evaluation. However, the TBS was significantly lower whereas aBMD did not show significant difference at the time of baseline DXA measurement (1st DXA, 1.343¡¾0.098 vs. 1.372¡¾0.06317, P<0.001; 2nd DXA, 1.342¡¾0.095 vs. 1.370¡¾0.062, P<0.001). The TBS and aBMD did not differ significantly between the initial and follow-up DXA images in both groups of TSH suppressive patients and controls.

Conclusions: The average value of TBS and aBMD did not significantly change during the follow-up period. The TSH suppressive therapy was revealed as not a significant factor for the progressive deterioration of bone status during long term follow-up.
KEYWORD
Absorptiometry, photon, Bone density, Postmenopause, Thyroid neoplasms
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed